XC8: Clinical Trials

4 trials of XC8, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 unknown. 2 Phase 1, 1 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Not applicable1Completed 1
Phase 31Unknown 1

Follow XC8: new trials by email Literature Review of XC8 trials Research Report on XC8

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of XC8, Film-coated Tablets, in Children With Acute Respiratory Viral Infections
XC8, Placebo - Acute Respiratory Infection
Phase 3UnknownValenta Pharm JSC2522023-12-042024-04-23
Pharmacokinetics and Bioequivalence of XC8 10 mg and 40 mg Tablets in Fasted Volunteers
XC8 - Influenza, Respiratory Viral Infection
Not applicableCompletedValenta Pharm JSC242022-08-222023-10-10
Study of the Effect of Food Intake on the Bioavailability of XC8 10 mg Film-coated Tablets
XC8 - Healthy
Phase 1CompletedValenta Pharm JSC242022-02-012023-07-27
XC8 Safety, Tolerability and Pharmacokinetics in Healthy Volunteers
XC8, Placebo - Asthma
Phase 1CompletedPHARMENTERPRISES LLC282015-02-142018-02-22

Conditions studied

Asthma (1)  ·  Influenza, Human (1)

Sponsors

Valenta Pharm JSC (3)  ·  PHARMENTERPRISES LLC (1)

Countries

Russia (4)